M E Lippman
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Protease and Inhibitor Mechanisms
- Genetics top 10%
- Estrogen and related hormone effects
Papers in
-
- Breast Cancer Treatment Studies 12
- Genetics 8
- Estrogen and related hormone effects 8
- Co-authors
- Charles Kent Osborne (1 shared paper)C. Ronald Kahn (1 shared paper)Michael D. Johnson (1 shared paper)Jeffrey A. Torri (1 shared paper)Robert B. Dickson (1 shared paper)Susan C. Aitken (2 shared papers)Audrey Barlock (2 shared papers)Joseph C. Allegra (2 shared papers)
- Journals
- PubMed (21 papers)
- Partner nations
- United States
In The Last Decade
M E Lippman
20 papers receiving 777 citations
Peers
Comparison fields: 5 of 49
- Cancer Research 366
- Genetics 315
- Oncology 115
- Endocrinology, Diabetes and Metabolism 58
- Molecular Biology 129
Countries citing papers authored by M E Lippman
This map shows the geographic impact of M E Lippman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M E Lippman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M E Lippman more than expected).
Fields of papers citing papers by M E Lippman
This network shows the impact of papers produced by M E Lippman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M E Lippman. The network helps show where M E Lippman may publish in the future.
Co-authors
The 25 scholars most cited alongside M E Lippman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer. | 1979 | 150 |
| 2 | Correlation among insulin binding, degradation, and biological activity in human breast cancer cells in long-term tissue culture. | 1978 | 126 |
| 3 | The role of cathepsin D in the invasiveness of human breast cancer cells. | 1993 | 122 |
| 4 | Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications. | 1993 | 120 |
| 5 | Association between steroid hormone receptor status and disease-free interval in breast cancer. | 1979 | 105 |
| 6 | Treatment of locally advanced breast cancer using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery. | 1986 | 65 |
| 7 | Effect of v-rasH oncogene transfection on estrogen-independent tumorigenicity of estrogen-dependent human breast cancer cells. | 1987 | 34 |
| 8 | Hormonal control of human breast cancer cell lines. | 1986 | 26 |
| 9 | Recombinant heregulin-Pseudomonas exotoxin fusion proteins: interactions with the heregulin receptors and antitumor activity in vivo. | 1998 | 25 |
| 10 | Receptors for steroid hormones in human melanoma. | 1976 | 24 |
| 11 | Growth regulation of human breast cancer. | 1985 | 22 |
| 12 | Treatment of patients with inflammatory breast cancer. | 1989 | 22 |
| 13 | National Institutes of Health Consensus Development Conference on Adjuvant Chemotherapy and Endocrine Therapy for Breast Cancer. Editorial overview. | 1986 | 7 |
| 14 | Systemic therapy of locally advanced breast cancer: review and guidelines. | 1989 | 7 |
| 15 | Relationship between estrogen-receptor proteins and response to chemotherapy in breast cancer. | 1984 | 5 |
| 16 | Management of advanced breast cancer in Africa: strategies in the absence of hormone receptor assay data. | 1985 | 4 |
| 17 | Women and breast cancer. | 1987 | 4 |
| 18 | Phase II trial of chlorozotocin in malignant melanoma, breast cancer, and other solid tumors. | 1982 | 3 |
| 19 | Problems in the development of cytotoxic moieties linked to hormones. | 1978 | 1 |
| 20 | Adjuvant systemic therapy of breast cancer. | 1985 | 1 |
About M E Lippman
M E Lippman is a scholar working on Cancer Research, Genetics, Toxicology, Oncology and Immunology, having authored 21 papers that have together received 873 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (12 papers), Estrogen and related hormone effects (8 papers), Toxin Mechanisms and Immunotoxins (2 papers), Bioactive Compounds and Antitumor Agents (2 papers), Cutaneous Melanoma Detection and Management (2 papers), Breast Lesions and Carcinomas (1 paper), Synthesis and biological activity (1 paper) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Cancer Research (366 citations), Genetics (315 citations), Oncology (115 citations), Endocrinology, Diabetes and Metabolism (58 citations) and Molecular Biology (129 citations). M E Lippman has collaborated with scholars based in United States. Frequent co-authors include Charles Kent Osborne, C. Ronald Kahn, Michael D. Johnson, Jeffrey A. Torri, Robert B. Dickson, Susan C. Aitken, Audrey Barlock, Joseph C. Allegra, E B Thompson and Carl E. Freter. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.